1-(3-Chlorobenzoyl)piperidin-3-ol

Catalog No.: 
ACKFNH148
CAS No.: 
1090598-28-9
Molecular Formula: 
C12H14ClNO2
Molecular Weight: 
239.70
1-(3-Chlorobenzoyl)piperidin-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$139.00InquiryInquiry
100mg98%$197.00InquiryInquiry
250mg98%$274.00InquiryInquiry
1g98%$660.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chlorobenzoyl)piperidin-3-ol
IUPAC Name(3-chlorophenyl)(3-hydroxypiperidin-1-yl)methanone
MDL No.MFCD11738635
Molecular FormulaC12H14ClNO2
Molecular Weight239.70
SMILESOC1CN(C(C2=CC=CC(Cl)=C2)=O)CCC1
InChI KeyJMOPOVWQVQBGKD-UHFFFAOYSA-N
Synonym1-(3-chlorobenzoyl)piperidin-3-ol;Methanone, (3-chlorophenyl)(3-hydroxy-1-piperidinyl)-;(3-Chlorophenyl)(3-hydroxypiperidin-1-yl)methanone
CAS No.1090598-28-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACKFNH148 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZDCA319 route compound structure diagram
    ACZDCA319535-80-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFNH148 route product structure diagram
    ACKFNH1481090598-28-9
Inquiry

2. ACKFNH148 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFNH148 route product structure diagram
    ACKFNH1481090598-28-9
Inquiry

3. ACKFNH148 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKFNH148 route product structure diagram
    ACKFNH1481090598-28-9
Inquiry

Comments (0)